icon-folder.gif   Conference Reports for NATAP  
 
  17th International Workshop
on Clinical Pharmacology of
HIV and Hepatitis Therapy
June 8-10, 2016, Washington DC
Back grey_arrow_rt.gif
 
 
 
Population Pharmacokinetic Analysis of
Velpatasvir, a Pangenotypic HCV NS5A Inhibitor,
in Healthy and Hepatitis C Virus-Infected Subjects

 
 
  Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, 8-10 June 2016, Washington, DC, USA
 
Brian Kirby,1 Erik Mogalian,1 Yuying Gao,2 Kavitha Bhasi,1 Anita Mathias1
1Gilead Sciences, Inc., Foster City, California, USA; 2Quantitative Solutions, Inc., Menlo Park, California

Clin1

Clin2

Clin3

Clin4

Clin5

Clin6

Clin7

Clin8

Clin9

Clin10

Clin11

Clin12

Clin13